- Home
- NUVB vs SLQT Comparison
NUVB vs SLQT Comparison
Compare NUVB & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- SLQT
- Stock Information
- Founded
- NUVB 2018
- SLQT 1999
- Country
- NUVB United States
- SLQT United States
- Employees
- NUVB N/A
- SLQT N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- SLQT Specialty Insurers
- Sector
- NUVB Health Care
- SLQT Finance
- Exchange
- NUVB Nasdaq
- SLQT Nasdaq
- Market Cap
- NUVB 679.9M
- SLQT 386.9M
- IPO Year
- NUVB N/A
- SLQT 2020
- Fundamental
- Price
- NUVB $2.12
- SLQT $2.26
- Analyst Decision
- NUVB Strong Buy
- SLQT Hold
- Analyst Count
- NUVB 6
- SLQT 2
- Target Price
- NUVB $7.83
- SLQT $3.38
- AVG Volume (30 Days)
- NUVB 7.6M
- SLQT 987.5K
- Earning Date
- NUVB 08-04-2025
- SLQT 05-12-2025
- Dividend Yield
- NUVB N/A
- SLQT N/A
- EPS Growth
- NUVB N/A
- SLQT N/A
- EPS
- NUVB N/A
- SLQT N/A
- Revenue
- NUVB $10,957,000.00
- SLQT $1,488,701,000.00
- Revenue This Year
- NUVB $101.21
- SLQT $17.72
- Revenue Next Year
- NUVB $410.28
- SLQT $13.05
- P/E Ratio
- NUVB N/A
- SLQT N/A
- Revenue Growth
- NUVB N/A
- SLQT 20.41
- 52 Week Low
- NUVB $1.54
- SLQT $1.62
- 52 Week High
- NUVB $3.97
- SLQT $6.86
- Technical
- Relative Strength Index (RSI)
- NUVB 50.61
- SLQT 46.15
- Support Level
- NUVB $2.06
- SLQT $2.30
- Resistance Level
- NUVB $2.43
- SLQT $2.69
- Average True Range (ATR)
- NUVB 0.15
- SLQT 0.12
- MACD
- NUVB 0.03
- SLQT 0.00
- Stochastic Oscillator
- NUVB 50.00
- SLQT 12.64
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.